RBC Capital analyst Deane Dray raised the firm’s price target on 3M (MMM) to $130 from $120 but keeps an Underperform rating on the shares. The company delivered a modest but broad-based Q3 operating beat and raise, with the positives that included stronger organic growth and progress on new product introductions, the analyst tells investors in a research note. RBC adds however that it continues to believe that the looming five categories of unaddressed and unreserved of multi-billion-dollar PFAS litigation is an underappreciated risk to the story.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMM:
